PACS Group (NYSE:PACS – Get Free Report) is expected to post its Q3 2026 results after the market closes on Wednesday, November 25th. Analysts expect PACS Group to post earnings of $0.5790 per share and revenue of $1.46 billion for the quarter. Interested persons may review the information on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 11:30 AM ET.
PACS Group (NYSE:PACS – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. On average, analysts expect PACS Group to post $2.05 EPS for the current fiscal year and $2.66 EPS for the next fiscal year.
PACS Group Stock Down 1.1%
PACS opened at $48.44 on Wednesday. The stock has a market cap of $7.69 billion, a PE ratio of 22.37, a P/E/G ratio of 1.59 and a beta of -0.14. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.22. PACS Group has a 52 week low of $14.09 and a 52 week high of $51.68. The business’s fifty day simple moving average is $45.48 and its 200 day simple moving average is $40.52.
Analyst Ratings Changes
Check Out Our Latest Analysis on PACS Group
Insider Buying and Selling
In other news, CEO Jason Murray sold 19,235 shares of the stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $50.64, for a total transaction of $974,060.40. Following the completion of the sale, the chief executive officer owned 53,934,866 shares of the company’s stock, valued at approximately $2,731,261,614.24. This represents a 0.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Joshua Jergensen sold 40,000 shares of the stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $50.11, for a total value of $2,004,400.00. Following the sale, the chief operating officer directly owned 2,416,320 shares of the company’s stock, valued at approximately $121,081,795.20. This trade represents a 1.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,545,550 shares of company stock worth $71,404,223. Company insiders own 70.10% of the company’s stock.
About PACS Group
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Featured Stories
- Five stocks we like better than PACS Group
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
